Key Takeaways
- Elon Musk's artificial intelligence firm, xAI, has reportedly secured $10 billion in new funding, pushing its valuation to an estimated $200 billion, according to sources cited by CNBC.
- The U.S. Senate failed to pass a Republican-backed stopgap funding bill by a vote of 44-48, intensifying concerns over a potential government shutdown.
- The U.S. plans $6 billion in new arms sales to Israel, a deal that includes Apache helicopters and infantry assault vehicles, with deliveries expected in 2-3 years.
- The Baker Hughes total U.S. rig count increased by three to 542 for the week ending September 19, marking the third consecutive weekly rise.
- Neuralink, another of Elon Musk's ventures, is set to launch a thought-to-speech clinical trial in the U.S. in October, aiming to translate thoughts into text.
xAI's Massive Funding Round Bolsters AI Ambitions
Elon Musk's artificial intelligence startup, xAI, has reportedly raised a substantial $10 billion in new capital, achieving a formidable $200 billion valuation. This significant funding round, reported by CNBC citing informed sources, underscores the intense investor interest and competitive landscape within the generative AI sector. The capital injection is expected to fuel xAI's infrastructure expansion and the continued development of its Grok AI chatbot, positioning it to further compete with other leading AI firms.
US Government Shutdown Threat Rises as Senate Bill Fails
The risk of a U.S. government shutdown has escalated after the Senate rejected a Republican-led stopgap funding bill. The measure failed to pass with a 44-48 vote, falling short of the 60 votes required for advancement. Democrats largely withheld their support, demanding higher spending for healthcare and a more bipartisan approach to funding legislation. The rejected bill, which had passed the House, aimed to keep federal agencies operating at current funding levels through November 21. Senate Majority Leader John Thune indicated that another vote on the House-passed bill would not occur today, leaving the path forward unclear as the September 30 funding deadline approaches.
US Greenlights $6 Billion Arms Package for Israel
The U.S. government is moving forward with plans for a $6 billion arms sale to Israel, according to reports from the Wall Street Journal. This comprehensive package includes 30 AH-64 Apache helicopters valued at $3.8 billion and 3,250 infantry assault vehicles worth $1.9 billion. While the sale signifies continued U.S. support, deliveries of these advanced weapons are anticipated to take between two and three years.
Baker Hughes Reports Third Consecutive Weekly Rise in Rig Count
In the energy sector, U.S. energy firms increased their oil and natural gas rigs for the third consecutive week, according to the latest report from Baker Hughes (BKR). The total U.S. rig count rose by three to 542 for the week ending September 19, reaching its highest level since July. Specifically, oil rigs saw an increase of two, reaching 418, while gas rigs remained steady at 118. This uptick suggests a renewed focus on drilling activity, despite a forecasted decline in U.S. spot crude prices for 2025.
Neuralink Prepares for Thought-to-Speech Human Trials
Elon Musk's brain-computer interface company, Neuralink, is preparing to launch its first U.S. clinical trial in October. The trial will focus on a thought-to-speech technology, aiming to enable individuals with speech loss due to conditions like ALS and stroke to communicate by translating their thoughts into text. The company received FDA approval for a human study in May and began recruitment approximately four months later. Neuralink aims to implant its brain device in a healthy person by 2030.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.